MedTrace Logo

Comparison of iGel and THRIVE on Bronchoscopic Interventions

NCT05046223 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 160

Last updated 2023-02-16

No results posted yet for this study

Summary

THRIVE and iGEL were applied for maintain oxygenation in bronchoscopic interventions which could not performed with an endotracheal tube. However, besides the risk of desaturation, the differences on difficulties to approach vocal cords, the responses to spay of local anesthetics including cough or spasm, the CO2 elimination, the hemodynamic changes, and the effects on postoperative recovery are rarely investigated.

Conditions

  • Lung Diseases
  • Total Intravenous Anesthesia
  • Tracheal Diseases

Interventions

PROCEDURE

The responses to bronchoscopic insertion for bronchoscopic interventions such asTBNA, Cryotherapy, etc.

cough response, the changes of BP, HR, SpO2, Trans dermal CO2 during bronchoscopic interventions

PROCEDURE

postoperative recovery

anesthetic recovery in postoperative care unit recovery of swallowing by questionnaire in POD1

Sponsors & Collaborators

  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Fu-Chang Tsai · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-20
Primary Completion
2022-12-31
Completion
2023-01-31

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05046223 on ClinicalTrials.gov